CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Fitzpatrick Jennifer Chief Legal Officer | Option exercise 10b5-1 | +10,250 | $6.11 | $63K | 10,250 |
| 2026-07-06 | Fitzpatrick Jennifer Chief Legal Officer | Sale 10b5-1 | −10,250 | $43.60 | $447K | 0 |
| 2026-07-06 | Fitzpatrick Jennifer Chief Legal Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,250 | 40,685 | ||
| 2026-06-30 | Thompson Peter A. Director | Sale 10b5-1 | −115,844 | $45.50 | $5.3M | 2,555,877 |
| 2026-06-30 | ORBIMED ADVISORS LLC Director | Sale 10b5-1 | −115,844 | $45.50 | $5.3M | 2,555,877 |
| 2026-06-17 | Ruddy Marcella K. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Fleming Harold Edward Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Viney Joanne L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Resnick Joshua Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Stelzer Laurie Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Booth Bruce Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Clancy Paul J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | Thompson Peter A. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,340 | 17,340 | ||
| 2026-05-27 | Thompson Peter A. Director | Sale 10b5-1 | −101 | $44.49 | $4K | 2,671,721 |
| 2026-05-27 | ORBIMED ADVISORS LLC Director | Sale 10b5-1 | −101 | $44.49 | $4K | 2,671,721 |
| 2026-05-11 | Thompson Peter A. Director | Sale 10b5-1 | −184,639 | $46.22 | $8.5M | 2,671,822 |
| 2026-05-11 | ORBIMED ADVISORS LLC Director | Sale 10b5-1 | −184,639 | $46.22 | $8.5M | 2,671,822 |
| 2026-05-08 | Thompson Peter A. Director | Sale 10b5-1 | −59,767 | $44.58 | $2.7M | 2,856,461 |
| 2026-05-08 | ORBIMED ADVISORS LLC Director | Sale 10b5-1 | −59,767 | $44.58 | $2.7M | 2,856,461 |
Page 2 of 15 · 284 trades